Alycia Hatashima

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 3

Top Topics

Emergency Department

Tyrosine Kinase

Chronic Lymphocytic Leukemia

Top Venues

Expert review of hematology

Future oncology (London, England)

Thyroid : official journal of the American Thyroid Association

This page only lists publications with an associated author ORCID identifier.

Publications

Alycia Hatashima, Mazyar Shadman
BTK inhibitors: moving the needle on the treatment of chronic lymphocytic leukemia. Expert review of hematology (2024)
Alycia Hatashima, Matthew J Arango, Joshua Reardon, Tracelyn Freeman, Terence Williams, Eric M McLaughlin, Laith Abushahin
First-line gemcitabine plus nab-paclitaxel versus FOLFIRINOX for metastatic pancreatic cancer in a real-world population. Future oncology (London, England) 18 (20) (2022)
Alycia Hatashima, Brianna Archambeau, Heather Armbruster, Menglin Xu, Manisha Shah, Bhavana Konda, Abberly Lott Limbach, Vineeth K Sukrithan
An Evaluation of Clinical Efficacy of Immune Checkpoint Inhibitors for Patients with Anaplastic Thyroid Carcinoma. Thyroid : official journal of the American Thyroid Association 32 (8) (2022)